The Valley Desk

NCT03790332 · Interventional trial

Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)

Overall registry status Completed

Phase 1 · Phase 2

Conditions Chronic Graft Versus Host Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov